Artificial Intelligence and Rare Cancers: Current Reality and Future Developments

Ownership: you are a person who thrives on taking responsibility and creating processes from scratch
Agility: you enjoy solving complex problems in a fast-paced environment
Collaboration: you believe that the best solutions come from diverse, cross-functional teams where initiative is valued
Communication: you are fluent in Italian and English

Davide Ruffo, Chief Corporate & Business Development Officer at Aindo, will be a speaker at the conference “Artificial Intelligence and Rare Cancers: Current Reality and Future Developments”, promoted by the Italian National Institute of Health (ISS).

Organized by the National Center for Preclinical and Clinical Research and Evaluation of Drugs (CNRVF) under the scientific direction of Dr. Anna La Salvia, the event analyzes the revolutionary impact of AI in managing rare cancers and neuroendocrine tumors, highlighting the latest technological and clinical innovations.

Aindo is proud to contribute to a crucial dialogue for the future of medical research and healthcare. To attend in person, registration is required by May 19 via the registration link.

Join Us

Want to learn more or work with us? We'd love to hear from you.